Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centella Asiatica for Xerotic Skin in Type 2 Diabetes
NCT03815305Phase 4Unknown
- Sponsor
- Universitas Indonesia
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- PE (Plant extract)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of centella asiatica extract in xerosis cutis (3 arms), sponsored by Universitas Indonesia. Primary endpoints: Change in Skin Capacitance at 1 month, Change in Superoxide Dismutase at 1 month and 3 more. Status: unknown.
02
Drugs
centella asiatica extract
03
Conditions
xerosis cutis
Beyond the preview
Go deeper on NCT03815305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03815305.